The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nurofen Rapid Relief Maximum Strength 400mg Liquid Capsules



Reckitt Benckiser Ireland LtdPA0979/032/013

Main Information

Trade NameNurofen Rapid Relief Maximum Strength 400mg Liquid Capsules
Active SubstancesIbuprofen
Dosage FormCapsule, soft
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/032/013

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued24/07/2009
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct is not subject to medical prescription, subject to the following conditions; Max. Dose 400mg, Max. Daily Dose 1200mg, Max. Pack Size: 25 (400mg)
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back